UBS Group’s Aegerion Pharmaceuticals AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-3,781
| Closed | -$11K | – | 8373 |
|
|
2016
Q3 | $11K | Sell |
3,781
-7,015
| -65% | -$12.2K | ﹤0.01% | 6758 |
|
|
2016
Q2 | $16K | Buy |
10,796
+10,021
| +1,293% | +$22.9K | ﹤0.01% | 6489 |
|
|
2016
Q1 | $3K | Sell |
775
-8,056
| -91% | -$49.9K | ﹤0.01% | 7260 |
|
|
2015
Q4 | $89K | Sell |
8,831
-11,147
| -56% | -$134K | ﹤0.01% | 5311 |
|
|
2015
Q3 | $272K | Buy |
19,978
+19,053
| +2,060% | +$339K | ﹤0.01% | 4391 |
|
|
2015
Q2 | $17K | Sell |
925
-1,450
| -61% | -$31.4K | ﹤0.01% | 7053 |
|
|
2015
Q1 | $62K | Sell |
2,375
-5,588
| -70% | -$142K | ﹤0.01% | 5854 |
|
|
2014
Q4 | $167K | Buy |
+7,963
| New | +$201K | ﹤0.01% | 5215 |
|